medigraphic.com

2009, Number 1

<< Back Next >>

Enf Infec Microbiol 2009; 29 (1)

Bioterrorism and public health

Soberanis RO, Ramos GC

Language: Spanish
References: 18
Page: 29-36
PDF size: 77.39 Kb.


ABSTRACT

Bioterrorism is the illegitimate use (or threat of use) of microorganisms or toxins derived from living organisms, to cause illness or death to humans, animals or plants, aiming to intimidate governments or societies to achieve ideological, religious or political goals. Being biological agents far more lethal than chemicals, as they are often more difficult to diagnose, and the clinical outsets similar to other diseases, they are also characterized by their lower cost, easy to acquire, culture, storing, and transporting.
There are few biological agents used in bioterrorism, they have been classified (class A, B and C) depending on their morbidity, mortality, ability to infect, existence of vaccine, availability, production potential, stability in the environment, ability to be diagnosed, and so on.
It is essential that health professionals and authorities have information about the epidemiology, diagnosis, treatment, prevention and control of these agents in order to develop emerging programs that meet the needs for this type of contingencies.


REFERENCES

  1. Secretaria de Salud. Plan Nacional de Protección de la Salud ante el Riesgo de Bioterrorismo: principios generales de preparación y respuesta 2004 México, DF.

  2. Brachman PS. “Bioterrorism: An Update with a Focus on Anthrax”. 2002; 155:981-987.

  3. Ponce LRS, Lazcano PE, Rangel FMS, Sosa LLA, Huerta JMA. “Bioterrorismo: apuntes para una agenda de lo inesperado”. 2001; 43:589-603.

  4. Franco PC, Del Río C, Nava FM, Rangel FS, Téllez I, Santos PJI. “Enfrentando el bioterrorismo: aspectos epidemiológicos, clínicos y preventivos de la viruela”. 2003;45:298-309.

  5. Rodríguez TJG, Monroy LJF. “¿Es posible el bioterrorismo en México?”. 2002; 2(1):8-13.

  6. Darling RG, Catlett CL, Huebner KD, Jarrett DG. “Threats in bioterrorism I: CDC category A agents”. 2002; 20:273-309.

  7. Moran GJ. “Threats in bioterrorism. II: CDC category B and C agents”. 2002; 20:311-30.

  8. Swart MN. “Recognition and management of anthrax--an update”. 2001; 345(22):1621-1626.

  9. Donaghy M. “Neurologists and the threat of bioterrorism”. 2006; 249:55-62.

  10. Eisen RJ, Bearden S, Wilder A, Montenieri J, Antolin M, Gage K. “Early-phase transmission of Yersinia pestis by unblocked fleas as a mechanism explaining rapidly spreading plague epizootics.” 2006; 103:15380-15385.

  11. Dennis D, Inglesby T, Henderson D; Bartlett J, Ascher M, Eitzen E, et al. “Tularemia as a biological weapon: medical and public health management”. JAMA 2001;285(21):2763-2773.

  12. Wiser I, Balicer RD, Cohen D. “An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies”. Vaccine 2007; 25(6):976-984.

  13. Drosten C, Göttig S, Schilling S, Asper M, Panning M, Schmitz H, Günther S. “Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean- Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription- PCR. J” Clin Microbiol 2002; 40(7):2323-2330.

  14. Pappas G, Blanco J, Oteo J. “Q fever in Logroño: an attack scenario”. Enferm Infecc Microbiol Clin 2007; 25:199-203.

  15. Turkmani A, Ioannidis A, Christidou A, Psaroulaki A, Loukaides F, Tselentis Y. “In vitro susceptibilities of isolates to eleven antibiotics”. Ann Clin Microbiol Antimicrob 2006; 2;5-24.

  16. Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, Maidhof H, Gouvras G. “Bichat guidelines for the clinical management of viral encephalitis and bioterrorismrelated viral encephalitis”. Euro Surveill 2004; 9(12):21-22.

  17. Chandy S, Yoshimatsu K, Ulrich RG, Mertens M, Okumura M, Rajendran P, et al. “Seroepidemiological study on hantavirus infections in India”. Trans R Soc Trop Med Hyg 2008; 102(1):70-74.

  18. Bonaldo MC, Mello SM, Trindade GF, Rangel AA, Duarte AS, Oliveira PJ, Freire MS, Kubelka CF, Galler R. “Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes”. Virol J 2007; 4:115-131.




2020     |     www.medigraphic.com